# Ottimo Pharma funding: rounds and investors

> Ottimo Pharma has raised $140M across 1 round since 2024. Investors include Avoro Capital, OrbiMed and JP Morgan. Every round with its source.

Source: https://millionrounds.com/company/ottimo-pharma (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Series A startup](https://millionrounds.com/companies)

# Who invested in *Ottimo Pharma*

One round we have observed, with the 10 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summary Updated 26 Oct 2026

**$140M** raised across 1 round since 2024, from 2 sources

- **Latest round:** Series A, $140M Dec 2024
- **Led by:** Avoro Capital
- **Investors:** 10 (1 led)

See who backed them

## The rounds

- **Dec 2024** Series A **$140M** [Avoro Capital](https://millionrounds.com/fund/avoro-capital) Lead [OrbiMed](https://millionrounds.com/fund/orbimed) [JP Morgan](https://millionrounds.com/fund/jpmorgan) [Janus Henderson Investors](https://millionrounds.com/fund/janus-henderson-investors) [Invus](https://millionrounds.com/fund/invus) [Samsara BioCapital](https://millionrounds.com/fund/samsara-biocapital) [RTW Investments LLC](https://millionrounds.com/fund/rtw-investments-lp) [Decheng Capital](https://millionrounds.com/fund/decheng-capital) [Medicxi](https://millionrounds.com/fund/medicxi) [J.P. Morgan Life Sciences Private Capital](https://millionrounds.com/fund/j-p-morgan-life-sciences-private-capital) Reported by Firms' own news pages and 1 other

## Funding filed with regulators

Ottimo Pharma filed 2 raises, $144M in all. Filings say how much was sold and to how many investors; they never name the investors.

- Dec 2024 **$143M** UK share allotment
- Oct 2024 **$412K** UK share allotment

## Founders and team

From Ottimo Pharma's own website: 8 on the team.

- **David Epstein** Chair & Chief Executive Officer
- **Mehdi Shahidi** Head of Development & Chief Medical Officer
- **Spencer Fisk** Chief Technical and Quality Officer
- **Julio Gagne** VP Business Development & Program Management
- **James Sabry** Vice-Chair
- **Ling Zeng** General Counsel and EVP of Execution
- **Samsara BioCapital** Board Director
- **Susan Singer** Director of Executive Operations

Advisers *Jonny Finlay*

## Everyone who backed them

[Avoro Capital](https://millionrounds.com/fund/avoro-capital) Investment firm **1** round, led 1

[OrbiMed](https://millionrounds.com/fund/orbimed) Private equity **1** round

[JP Morgan](https://millionrounds.com/fund/jpmorgan) Investment bank **1** round

[Janus Henderson Investors](https://millionrounds.com/fund/janus-henderson-investors) Private equity **1** round

[Invus](https://millionrounds.com/fund/invus) Private equity **1** round

[Samsara BioCapital](https://millionrounds.com/fund/samsara-biocapital) VC firm **1** round

[RTW Investments LLC](https://millionrounds.com/fund/rtw-investments-lp) Growth equity **1** round

[Decheng Capital](https://millionrounds.com/fund/decheng-capital) VC firm **1** round

[Medicxi](https://millionrounds.com/fund/medicxi) VC firm **1** round

[J.P. Morgan Life Sciences Private Capital](https://millionrounds.com/fund/j-p-morgan-life-sciences-private-capital) VC firm **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=ottimo-pharma).

## Also claim to have backed them

This firm lists Ottimo Pharma as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

[Avoro Capital Advi...](https://millionrounds.com/fund/avoro-capital-advi) Private equity Per its own site

## Quick answers about Ottimo Pharma

### Who invested in Ottimo Pharma?

Ottimo Pharma's investors include Avoro Capital, OrbiMed, JP Morgan, Janus Henderson Investors and Invus, and 5 more on record. Avoro Capital led its latest round.

### How much has Ottimo Pharma raised?

Ottimo Pharma has raised $140M across 1 round since 2024.

### When did Ottimo Pharma last raise?

Ottimo Pharma's most recent round was a Series A of $140M in Dec 2024, led by Avoro Capital.

### What was Ottimo Pharma's biggest round?

Its most recent round, $140M in Dec 2024, is also its largest on record.

### Who backed Ottimo Pharma first?

Ottimo Pharma's first round on record, in Dec 2024, was backed by Avoro Capital, OrbiMed and JP Morgan and 7 others.

### What stage is Ottimo Pharma at?

Ottimo Pharma's latest named round is a Series A, in Dec 2024.

### Where is Ottimo Pharma based?

Ottimo Pharma is based in the United Kingdom.

### Who led Ottimo Pharma's rounds?

Avoro Capital led the Series A in 2024.

## Companies like Ottimo Pharma

In the same sector, and raised in the last eighteen months.

[**HydRegen** $12M · Oct 2026](https://millionrounds.com/company/hydregen)[**OMass Therapeutics** $442M · Oct 2026](https://millionrounds.com/company/omass-therapeutics)[**CMR Surgical** $1.1B · Oct 2026](https://millionrounds.com/company/cmr-surgical)[**Living Optics** $61M · Oct 2026](https://millionrounds.com/company/living-optics)[**Bactobio** $18M · Oct 2026](https://millionrounds.com/company/bactobio)[**RHYTHM AI** $23M · Sept 2026](https://millionrounds.com/company/rhythm-ai)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app